{
  "ticker": "ABV",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02973605",
  "id": "02973605",
  "pages": 7,
  "price_sensitive": true,
  "date": "20250729",
  "time": "0828",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250729/pdf/06m7kdcjywpsxr.pdf",
  "summary": "### **Quarterly Report (Appendix 4C) Summary**  \n**Operational/Financial Highlights:**  \n- **Sales Revenue (Q4 FY25):** $5.6M (+27% pcp).  \n- **FY25 Sales Revenue:** $18.7M (+27% pcp).  \n- **Reported NPAT (FY25):** $1.78M (+5% pcp).  \n- **Underlying NPAT (ex-R&D tax rebate):** $1.08M (+87% pcp).  \n- **Cash Balance (EOQ):** $2.9M (+19% vs. FY24).  \n- **International Growth:** Export revenue up 47% (key markets: Indonesia, Mongolia, Canada).  \n\n**Capital Markets Impact:**  \n- **R&D Tax Incentive:** Delayed to FY26 due to consolidated tax grouping.  \n- **Debt Facility:** $310K drawn (unsecured insurance funding at 4.59%), $1.5M standby credit available.  \n- **Loans to Management:** $503K provided for option exercises (6% interest, 2-year term).  \n\n*Non-material details (director changes, operational commentary) omitted.*",
  "usage": {
    "prompt_tokens": 4870,
    "completion_tokens": 256,
    "total_tokens": 5126,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-28T22:50:01.240185"
}